Platinum will help generate real-world data to translate the clinical safety and efficacy demonstrated in FDA pivotal trials into everyday practice across multiple trials and evaluation programs.

Program Designed to Drive Real World, Practice Focused Evidence with Injectables & SkincareNEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed ...

Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), ...

NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Obagi Medical (“Obagi”), the fastest growing professional skincare brand in the U.S. in 2024*, proudly unveils its latest innovation rooted in clinical skin ...

Waldencast plc has acquired Novaestiq Corp. and the U.S. rights to the Saypha® line of hyaluronic acid injectables, significantly enhancing Obagi Medical's product offerings in the aesthetics market.

What's your favourite beauty treatment? My favourite beauty treatment is medical-grade skincare – but it's important to come off it when you don't need it! I'm on the Obagi treatment and I really ...

Co announces results from a multi-center, randomized, controlled investigator-blinded study evaluating the use of Nu-Derm, a hydroquinone-based skin care system, to help improve the scar cosmesis ...